Results 41 to 50 of about 74,663 (286)

Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease

Diabetes, Metabolic Syndrome and Obesity, 2022
Hang Yin, Anhua Shi, Junzi Wu Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, People’s Republic of ChinaCorrespondence: Junzi Wu; Anhua Shi, Key Laboratory of Microcosmic Syndrome Differentiation ...
Yin H, Shi A, Wu J
doaj  

Platelet-activating factor (PAF) enhances guinea pig detrusor smooth muscle contractile activities by stimulating voltage-dependent Ca2+ channels and store-operated Ca2+ channels

Journal of Pharmacological Sciences, 2023
We investigated the extracellular Ca2+ influx pathways involved in platelet-activating factor (PAF)-enhanced guinea pig detrusor smooth muscle (DSM) contractile activities.
Keisuke Obara, Mizuki Kaneko, Mio Yamashita, Ge Liu, Kento Yoshioka, Yoshio Tanaka   +5 more
doaj   +1 more source

Radiation therapy generates platelet-activating factor agonists [PDF]

, 2016
Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R).
Chin-Sinex, Helen Jan, Dynlacht, Joseph R., Garrett, Joy Elizabeth, Harrison, Kathleen A., Johnston II., Michael Edward, Konger, Raymond L., Li, Gengxin, McMullen, Kevin, Mendonca, Marc, Murphy, Robert C., Sahu, Ravi P., Spandau, Dan F., Travers, Jeffrey B., Weyerbacher, Jonathan   +13 more
core   +2 more sources

Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions [PDF]

, 1999
The integrin heterodimer CD11b/CD18 (alpha M beta 2, Mac-1, CR3) expressed on monocytes or polymorphonuclear leukocytes (PMN) is a receptor for iC3b, fibrinogen, heparin, and for intercellular adhesion molecule (ICAM)-1 on endothelium, crucially ...
Amatruda TT, Bednar MM, Bellosta S, Buttrum SM, Buyon JP, Calara F, Calderon TM, Diacovo TG, Giroux LM, Jukema JW, Kim JA, Kimura M, Laufs U, Laws KH, Lehr H-A, Marcus AJ, Notabartolo A, Olstrowsky L, Pons F, Ruf A, Smalley DM, Stragliotto E, Sugiyama S, Weber C, Weber C, Weber C, Yeagle PL, Yeo EL, Yue TL   +28 more
core   +1 more source

Effect of safflower yellow on platelet activating factor mediated platelet activation in patients with coronary heart disease

Bangladesh Journal of Pharmacology, 2012
The platelet aggregation and 5-HT release by washed platelet from coronary heart disease patients following platelet activating factor (PAF) treatment were detected by turbidimetry and O-phthalaldehyde assay.
Damin Huang, Yingmin Lu, Xiaohan Luo, Laixin Shi, Jinchun Zhang, Junxian Shen, Minmin Bao, Lei Song, Caiwen Wei, Hongsong Li, Zhihua Li   +10 more
doaj   +1 more source

Reversible cross-tolerance to platelet-activating factor signaling by bacterial toxins

Platelets, 2021
Bacterial toxins signaling through Toll-like receptors (TLRs) are implicated in the pathogenesis of many inflammatory diseases. Among the toxins, lipopolysaccharide (LPS) exerts its action via TLR-4 while lipoteichoic acid (LTA) and bacterial ...
Kandahalli Venkataranganayaka Abhilasha, Mosale Seetharam Sumanth, Anita Thyagarajan, Ravi Prakash Sahu, Kempaiah Kemparaju, Gopal Kedihithlu Marathe   +5 more
doaj   +1 more source

Apafant, a Potent Platelet-Activating Factor Antagonist, Blocks Eosinophil Activation and Is Effective in the Chronic Phase of Experimental Allergic Conjunctivitis in Guinea Pigs

Journal of Pharmacological Sciences, 2004
Platelet-activating factor (PAF) plays important roles in allergic reactions. In particular, there are many concerns about PAF, eosinophils, and the chronicity of allergic diseases.
Masatomo Kato, Kenji Imoto, Hideki Miyake, Tomoko Oda, Suguru Miyaji, Masatsugu Nakamura   +5 more
doaj   +1 more source

Structural identification of oxidized acyl-phosphatidylcholines that induce platelet activation [PDF]

, 2005
Oxidation of low-density lipoprotein (LDL) generates proinflammatory and prothrombotic mediators that may play a crucial role in cardiovascular and inflammatory diseases.
Berliner JA, Bittman R, Casals-Stenzal J, Esterbauer H, Fernandez-Ortiz A, Frey B, Goetzl EJ, Holvoet P, Itabe H, Kamido H, Kamido H, Kern H, Kinsella BT, Kitagawa S, O'Flaherty JT, O'Flaherty JT, Rasmussen UB, Sevanian A, Subbanagounder G, Tanaka T, Trip MD, Volf I, Watson AD, Weidtmann A   +23 more
core   +1 more source

Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery*

Journal of Lipid Research, 2008
Platelet-activating factor (PAF), the potent phospholipid mediator of inflammation, is involved in atherosclerosis. Platelet-activating factor-acetylhydrolase (PAF-AH), the enzyme that inactivates PAF bioactivity, possesses both acetylhydrolase and ...
Demokritos C. Tsoukatos, Isabelle Brochériou, Vassilios Moussis, Christina P. Panopoulou, Elena D. Christofidou, Stamatis Koussissis, Socratis Sismanidis, Ewa Ninio, Stavros Siminelakis   +8 more
doaj   +1 more source

Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein [PDF]

, 2006
Oxidation of low-density lipoprotein (LDL) generates pro-inflammatory and pro-thrombotic mediators that play a crucial role in cardiovascular and inflammatory diseases.
Siess, Wolfgang
core   +1 more source